Back
Evoke Pharma, Inc. 10K Form
Buy
59
EVOK
Evoke Pharma, Inc.
Last Price:
$11.00
Seasonality Move:
9.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-14 | 10Q | EVOK/Evoke Pharma, Inc. Quarterly |
| 2023-11-09 | 10Q | EVOK/Evoke Pharma, Inc. Quarterly |
| 2023-08-10 | 10Q | EVOK/Evoke Pharma, Inc. Quarterly |
| 2023-05-15 | 10Q | EVOK/Evoke Pharma, Inc. Quarterly |
| 2022-11-09 | 10Q | EVOK/Evoke Pharma, Inc. Quarterly |
| 2022-08-10 | 10Q | EVOK/Evoke Pharma, Inc. Quarterly |
Receive EVOK News And Ratings
See the #1 stock for the next 7 days that we like better than EVOK
EVOK Financial Statistics
Sales & Book Value
| Annual Sales: | $10.2M |
|---|---|
| Cash Flow: | $-522K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.95 |
| Price / Book: | 5.64 |
Profitability
| EPS (TTM): | -2.38260 |
|---|---|
| Net Income (TTM): | $-5.2M |
| Gross Margin: | $9.9M |
| Return on Equity: | -104.51% |
| Return on Assets: | -32.76% |
Evoke Pharma, Inc. Earnings Forecast
Key Evoke Pharma, Inc. Financial Ratios
-
The Gross Profit Margin over the past 14 years for EVOK is 96.52%.
-
The Selling, General & Administrative Expenses for EVOK have been equal to 147.14% of Gross Profit Margin.
-
The Research & Development expenses have been 0.16% of Revenue.
-
The Net Earning history of EVOK is -52.22% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 10 years.
Evoke Pharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | EVOK |
| CUSIP: | 30049G |
| Website: | evokepharma.com |
Debt
| Debt-to-Equity Ratio: | 1.52 |
|---|---|
| Current Ratio: | 1.27 |
| Quick Ratio: | 1.21 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 16.18 |
EVOK Technical Analysis vs Fundamental Analysis
Buy
59
Evoke Pharma, Inc. (EVOK)
is a Buy
Is Evoke Pharma, Inc. a Buy or a Sell?
-
Evoke Pharma, Inc. stock is rated a BuyThe current Evoke Pharma, Inc. [EVOK] share price is $11.00. The Score for EVOK is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.